🔎 Trials Near Me

Início › Linfoma › New Jersey

Ensaios clínicos de Linfoma em New Jersey

18 estudos para Linfoma estão buscando participantes em locais em New Jersey.

Cidades em New Jersey

Texto oficial do estudo (Inglês)

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Hackensack University Medical Center - John Theurer Cancer C - Lymphoma Division, Hackensack
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07192471

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

  • Rutgers Cancer Institute of New Jersey, New Brunswick
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07015242

Rutgers University Study of the Genetics of Blood Cancers

  • Rutgers University, Piscataway
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 18 a 110 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07714044

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT02974647

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT04301076

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

  • Research Site, Basking Ridge
RecrutandoFase 3
Idades de 18 a 18 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07509151

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  • Rutgers Cancer Institute of New Jersey, New Brunswick
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06084936

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Atlantic Health, Morristown
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT04588922

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • John Theurer Cancer Center Hackensack University Medical Center, Hackensack
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT05826535

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge
  • Hackensack Meridian Health (Data collection only), Hackensack
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT05389293

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Hackensack, Hackensack
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

  • Hackensack Meridian Health, Nutley
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT06960993

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de jun. de 2026 · NCT07137494

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

  • Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (All protocol activities), Montvale
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 26 de mai. de 2026 · NCT07052916

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Hackensack University Medical Center, Hackensack
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT01790152

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

  • Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mar. de 2026 · NCT06698003

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
RecrutandoEstudo observacional
Idades 18 e acima · Mulheres · Atualizado em 4 de mar. de 2026 · NCT01788839

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Todas as idades · Todos os sexos · Atualizado em 23 de jan. de 2026 · NCT00582621

Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.